• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Discovery Laboratories Inc

+ Add to Watchlist


1.420 EUR 0.0000.00%

As of 02:16:12 ET on 04/17/2014.

Snapshot for Discovery Laboratories Inc (DYBN)

Open: 1.387 Day's Range: 1.386 - 1.420 Volume: 0
Previous Close: 1.420 52wk Range: 1.098 - 2.411 1-Yr Rtn: +7.66%

Stock Chart for DYBN

No chart data available.
  • DYBN:GR 1.420
  • 1D
  • 1M
  • 1Y
Interactive DYBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYBN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -0.6703
Est. EPS (USD) (12/2014) -0.5950
Est. PEG Ratio -
Market Cap (M EUR) 120.27
Shares Outstanding (M) 84.70
30 Day Average Volume 661
Price/Book (mrq) 19.2756
Price/Sale (ttm) 252.7333
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYBN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYBN

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.

John R LeoneChairmanJohn G CooperPresident/CEO
John A TattorySenior VP/CFOThomas F MillerSenior VP/COO
More Company Profile & Key Executives for DYBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil